Contact Us

Bifilac Lozenge

Home / Probiotics

Pre & Probiotics

Bifilac Lozenge

BIFILAC Lozenge contains, Streptococcus faecalis/ T-110, Clostridium butyricum TO-A, Bacillus mesentericus TO-A which are patented strains, licensed from TOA Pharmaceuticals Co. Ltd, Japan and Lactic acid bacillus (Lactobacillus  sporogenes), which is a time-tested probiotic strain. Through their symbiotic action they produce certain factors which inhibit bad micro-organisms and increase the count of beneficial  micro-organisms in the oral cavity. 

Manufacturer

Manufacturer

Tablets India Ltd
Form

Form

Lozenge
Composition
Composition
Pre & Probiotics
Key Ingredients
  • Streptococcus faecalis T-110 JPC - 30 million
  • Clostridium butyricum TO-A - 2 million
  • Bacillus mesentericus TO-A - 1 million
  • Lactic acid bacillus (Lactobacillus sporogenes) - 50 million
Get more details

Latest from Blog